These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7306434)

  • 1. Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo.
    Whitsett TL; Manion CV; Wilson MF
    Br J Clin Pharmacol; 1981 Aug; 12(2):195-200. PubMed ID: 7306434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial of oral clenbuterol (NAB 365) in chronic airways obstruction.
    Brusasco V; Crimi E; Mangini S; Vibelli C
    Curr Med Res Opin; 1980; 6(7):449-55. PubMed ID: 6988173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous NAB 365 (clenbuterol) and terbutaline in exercise-induced bronchospasm (EIB).
    Del Bono N; Quartieri F; Vibelli C
    Clin Allergy; 1979 May; 9(3):277-82. PubMed ID: 466753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma.
    Boner AL; Sette L; Castellani C; Schiassi M
    J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the cardiac and hemodynamic side-effects of the beta 2-adrenergic broncholytic agent clenbuterol (Contraspasmin)].
    Femmer K; Heer S
    Pharmazie; 1982 Aug; 37(8):584-6. PubMed ID: 7146067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration].
    Schaffler K; Schuster D
    Arzneimittelforschung; 1985; 35(8):1299-302. PubMed ID: 3907640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Placebo-controlled comparative study of clenbuterol and terbutaline in asthmatic children].
    Valente Mérida J; Medina J
    Rev Alerg Mex (1987); 1989; 36(2):61-4. PubMed ID: 2665027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
    Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S
    Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steric aspects of formoterol and terbutaline: is there an adverse effect of the distomer on airway smooth muscle function?
    Källström BL; Sjöberg J; Waldeck B
    Chirality; 1996; 8(8):567-73. PubMed ID: 9025256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.
    Baronti A; Grieco A; Vibelli C
    Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary function tests with the bronchodilator Terbutaline].
    Kaik G; Bonelli J; Hitzenberger G; Laggner A; Magometschnigg D
    Acta Med Austriaca Suppl; 1979; 14():1-39. PubMed ID: 161461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in blood potassium induced by the abuse of 3 beta 2-agonist drugs].
    Capretti A; Dantes M; De Gasperi R; D'Ambrosio V
    Clin Ter; 1987 Apr; 121(1):41-4. PubMed ID: 2954751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the oral beta-mimetic drug clenbuterol (Contraspasmin, Spiropent) and orally and intravenously administered Partusisten on the rheobase].
    Weisbach W; Niedner W; Wagner F; Jäger KH
    Zentralbl Gynakol; 1985; 107(11):664-9. PubMed ID: 4024779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD).
    Erichsen DF; Aviad AD; Schultz RH; Kennedy TJ
    Equine Vet J; 1994 Jul; 26(4):331-6. PubMed ID: 8575403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of clenbuterol as a repartitioning agent.
    Brockway JM; MacRae JC; Williams PE
    Vet Rec; 1987 Apr; 120(16):381-3. PubMed ID: 3590599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung function studies with the bronchodilator terbutaline].
    Kaik G; Bonelli J; Hitzenberger G; Laggner A; Magometschnigg D
    Acta Med Austriaca; 1979; 6(2):1-39. PubMed ID: 517068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clenbuterol ("Spiropent'): a long-acting bronchodilator.
    Wheatley D
    Curr Med Res Opin; 1982; 8(2):113-9. PubMed ID: 7049586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.